Abstract
LBA82 - Pembrolizumab (pembro) + chemotherapy (chemo) in metastatic squamous NSCLC: Final analysis and progression after the next line of therapy (PFS2) in KEYNOTE-407
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have